A Clinical Trial of TQC3721 Suspension for Inhalation in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease

Clinical trial NCT06527144 · COMPLETED

Trial details

NCT number: NCT06527144
Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Pulmonary Disease, Chronic Obstructive

Start date: 2024-09-14
Primary completion: 2025-01-16
Enrollment: 240

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.